NCT06811350Active, not recruiting
Quality Improvement Initiative for Enhancing Early Mobilization in Intracerebral Hemorrhage Patients
Quality Improvement Initiative for Enhancing Early Mobilization in Intracerebral Hemorrhage Patients: Pre-Post Implementation of a Structured Clinical Pathway
Source: ClinicalTrials.gov · Last updated 18 Nov 2025
Brief summary (registry, in English)
Primary intracerebral hemorrhage (ICH) is a severe and life-threatening condition with a high mortality rate, reaching up to 50% within the first month. Survivors are often at risk of long-term disability due to the extensive brain damage caused by the hemorrhage. Unlike ischemic stroke patients, ICH patients are typically younger, face longer hospital stays, and are more likely to experience acute complications. Modern treatment approaches have shifted from focusing solely on reducing mortality to minimizing disability and enhancing functional outcomes through early rehabilitation. However, the optimal timing and intensity of early mobilization remain unclear, especially for patients with severe ICH, where medical stability is a major concern. Delays in initiating rehabilitation may limit neuroplasticity and hinder recovery, prompting the need for a structured, multidisciplinary approach to early mobilization in ICH patients. Objective : This quality improvement (QI) initiative aimed to enhance early mobilization in ICH patients by implementing a structured clinical pathway in an academic stroke center. The goal was to integrate evidence-based early mobilization pathways to improve patient mobility outcomes while ensuring safety through standardized assessments of cardiovascular, respiratory, and neurological stability.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 198 (estimated)
- First submitted
- 13 Jan 2025
- Start date
- 28 Nov 2024
- Primary completion date
- 14 Feb 2025
- Lead sponsor
- National Taiwan University Hospital
- Diseases
- Stroke
- NCT number
- NCT06811350
What you commit to
- Study type: Observational
- Planned participants: 198
- From 28 Nov 2024 to the primary completion date, 14 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with traumatic brain injury, hemorrhagic transformation of ischemic stroke, or hemorrhage related to underlying malignancy
Other
- Patients placed in palliative care or those who died before initial hospital discharge
Who the study is looking for
- Clinical diagnosis of primary ICH
- ICH score from 0 to 4
- Patients In line with the stroke center's standard criteria for early rehabilitation
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Taiwan University Hospital Coordinator of this site? Confirm its status | Tiapei | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.